Efficacy of anakinra for idiopathic and non-idiopathic pericarditis refractory or intolerant to conventional therapy

Background: Anakinra, a recombinant interleukin-1 receptor antagonist is effective in treatment of idiopathic recurrent pericarditis. However, its efficacy in non-idiopathic pericarditis (secondary to a diagnosed inflammatory condition, or other known etiology) is unclear. We evaluated the efficacy...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European heart journal. Acute cardiovascular care 2020-12, Vol.9 (8), p.888-892
Hauptverfasser:	Shaukat, Muhammad HS, Singh, Sukhraj, Davis, Kathryn, Torosoff, Mikhail, Peredo-Wende, Ruben
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - therapeutic use Drug Tolerance Female Follow-Up Studies Humans Inpatients Interleukin 1 Receptor Antagonist Protein - therapeutic use Male Middle Aged Pericarditis - drug therapy Recurrence Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!